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Abstract – Shedding of prions via faeces may be involved in the transmission of contagious prion diseases.
Here, we fed hamsters 10mg of 263K scrapie brain homogenate and examined the faecal excretion of
disease-associated prion protein (PrP
TSE) during the course of infection. The intestinal fate of ingested
PrP
TSE was further investigated by monitoring the deposition of the protein in components of the gut
wall using immunohistochemistry and parafﬁn-embedded tissue (PET) blotting. Western blotting of faecal
extracts showed shedding of PrP
TSE in the excrement at 24–72h post infection (hpi), but not at 0–24hpi or
at later preclinical or clinical time points. About 5% of the ingested PrP
TSE were excreted via the faeces.
However, the bulk of PrP
TSE was cleared from the alimentary canal, most probably by degradation, while
an indiscernible proportion of the inoculum triggered intestinal infection. Components of the gut-associated
lymphoid tissue (GALT) and the enteric nervous system (ENS) showed progressing accumulation of PrP
TSE
from 30 days post infection (dpi) and 60dpi, respectively. At the clinical stage of disease, substantial
deposits of PrP
TSE were found in the GALT in close vicinity to the intestinal lumen. Despite an apparent
possibility of shedding from Peyer’s patches that may involve the follicle-associated epithelium (FAE),
only small amounts of PrP
TSE were detected in faeces from clinically infected animals by serial protein
misfolding cyclic ampliﬁcation (sPMCA). Although excrement may thus provide a vehicle for the release
of endogenously formed PrP
TSE, intestinal clearance mechanisms seem to partially counteract such a mode
of prion dissemination.
prion / oral infection / Peyer’s patches / enteric nervous system / faeces
1. INTRODUCTION
Transmissible spongiform encephalo-
pathies (TSE), also termed prion diseases [1],
such as scrapie in sheep and goats, bovine
spongiform encephalopathy (BSE), chronic
wasting disease (CWD) of elk and deer, or
human Creutzfeldt-Jakob disease (CJD) and
its variant form vCJD are neurodegenerative
and ultimately fatal diseases of the central ner-
vous system (CNS). Characteristically, TSE
* Corresponding author: BeekesM@rki.de
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are associated with the deposition in the brain
and spinal cord of a pathological form of the
prion protein (PrP) with an abnormally altered
folding and/or aggregation structure. The
prion hypothesis holds that the causative and
transmissible agents of TSE consist in pro-
teinaceous infectious particles (“prions”) that
are composed essentially – if not entirely – of
misfolded PrP, designated as PrPSc [36, 37].
Disease-associated prion protein, in the fol-
lowing referred to as PrPTSE [8, 13], can be
detected in samples from affected animals
or humans by analytical methods such as
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Figure 1. Time scale displaying the preclinical and clinical phases of incubation of hamsters orally infected
with 263K scrapie and indicating the time points at which samples from the animals were collected and
tested for PrP
TSE. Faeces samples collected at 0–24, 24–48, 48–72 and 72–96hpi were referred to in the
ﬁgure as specimens from 0, 1, 2, and 3 dpi, respectively.
immunohistochemistry (IHC) [22, 33, 47],
Western blotting [5, 40, 52], or parafﬁn-
embedded tissue (PET) blotting [41].
In naturally acquired scrapie, CWD, BSE,
and vCJD, infection seems to occur most often
by ingestion of TSE agents and subsequent
invasion of the host via the alimentary tract [8,
28]. Scrapie of sheep and goats and CWD of
cervids are contagious diseases that are trans-
mitted horizontally in the ﬁeld. Contaminated
placenta, decomposed carcasses, saliva, urine
or skin have been suggested as the contagion
of these diseases [15,30,34,38,42,46], but fae-
ces provide a further candidate vehicle for the
release of prions into the environment [29,39].
In the past, hamsters orally challenged with
scrapie have been established as a relevant
rodentmodeltostudytheintestinalpathophys-
iology of alimentary prion infections by taking
advantage of PrPTSE as a biochemical marker
for infectious prions [7,8,33].
Here, we used the hamster model of oral
scrapie infection in an attempt to further
elucidate pathophysiological events in the
intestinal tract following ingestion of prions.
In this context, special attention was given
to the intestinal fate of ingested PrPTSE,t h e
course of PrPTSE accumulation in the GALT
and the ENS, and the shedding of PrPTSE in
faeces.
2. MATERIALS AND METHODS
2.1. Animal inoculation
All animal experiments were performed using
outbred Syrian hamsters. The studies in animals
complied with German legal regulations and
were approved by the responsible review boards.
Hamsters were fed food pellets doused each with
100L of a 10% (w/v) hamster-brain homogenate
derived from terminally ill donors infected with
263K scrapie agent, and control animals were mock
challenged with brain homogenate from normal
hamsters as described previously [3].
2.2. Biochemical detection of PrP
TSE in faeces
For sampling of faeces, hamsters were placed
in metabolic cages (Harvard Apparatus, Holliston,
USA) with free access to food and drinking water.
Animals were transferred into metabolic cages once
they had ingested the infectious inoculum, and
faecal samples were collected at 0–24hpi, 24–
48hpi,48–72hpi,72–96hpi,at70,100,and130dpi
prior to the onset of scrapie symptoms, and when
the animals were in advanced clinical stages of
the disease between 145 and 160dpi (see Fig. 1).
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Faeces from individual animals (n ≥ 8 for each
investigated time point) sampled before they were
perorally challenged with scrapie agent served as
negative controls.
A 10% (w/v) faecal homogenate, adjusted
with normal hamster brain homogenate as carrier
material to a ﬁnal concentration of 0.125% (w/v)
brain tissue, was prepared with an ultraturrax
in TBS buffer (50mM Tris/HCl, 150mM NaCl,
pH 7.2). Extraction of PrP
TSE from the faecal
homogenate was performed by using a previously
published protocol [4] with modiﬁcations. In brief:
A total of 2mL sample homogenate (containing
200mg of faeces) was distributed equally on two
1.5mL centrifuge vials. All centrifugations were
performed in a TLA-55 rotor (Beckman). Samples
were centrifuged at 5000rpm (1500 × g)a n d
4 ◦C for 3min, the supernatants were collected
and the pellets resuspended in 0.5mL TBS each.
These suspensions were submitted to a second
centrifugationat5000rpm(1500 × g,4◦C,3min),
and the resulting supernatants were collected and
mixed with the supernatants from the previous
centrifugation and centrifuged again for 40min at
20000rpm (25000 × g)a n d4◦C.
The resulting pellets were resuspended in
600L 1% (w/v) sarcosyl in TBS using an
ultrasonic probe and centrifuged for 40min at
20 ◦C and 20000rpm (25000 × g). The resulting
supernatants were pooled and submitted to a further
centrifugation at45000rpm(125000 × g)a n d4◦C
for 2.5h. The resulting pellet was resuspended
in 1mL 0.1% sarcosyl in TBS, homogenized
by ultrasoniﬁcation, and incubated with constant
shaking at 37 ◦C in the presence of 12.5 g/mL
proteinase K (PK) for 15min. After a ﬁnal
centrifugation for 2.5h at 45000 rpm (125000 × g)
and 4 ◦C, the resulting pellet was suspended in
20Lo f2× Laemmli sample buffer, boiled for
5min and stored at −80 ◦C until further processing.
The ﬁnal pellet contained PrP
TSE in the form of its
PK-resistant core PrP27-30, which was visualized
by Western blotting using CDP-Star solution as
described elsewhere [44].
A subset of faecal samples from clinically-ill
scrapie hamsters was subjected to serial protein
misfolding cyclic ampliﬁcation (sPMCA) for
detection of PrP
TSE. Here, extraction of PrP
TSE was
performed as described above with the following
modiﬁcations: Treatment with PK was omitted
during the extraction, and the resulting pellet of
the ﬁnal centrifugation (2.5h at 45000rpm and
4 ◦C) was resuspended directly in 10% (w/v)
normal brain homogenate in PMCA conversion
buffer (phosphate buffered saline containing
complete protease inhibitor cocktail by Boehringer-
Ingelheim, Mannheim, Germany, 4mM EDTA and
1% Triton-X-100). Serial PMCA was performed as
described recently [43].
Faecal samples spiked with 263K scrapie
hamster brain homogenate served as positive
controls and were used to assess the detection
limit of our assay. If not otherwise stated, samples
representing 200mg of faeces in the starting
homogenates were loaded onto gels for Western
blotting of unknown and control faecal specimens.
In order to visualize the immunological cross-
reactivity of crude faecal material 100mg of
normal hamster faeces were homogenized in
400L2 × Laemmli sample buffer, boiled for
10min and centrifuged at 13000 rpm (13000
×g). Ten microliters of the resulting supernatant
(representing 2mg of faeces in the starting
homogenate) were then loaded onto the gel for mAb
3F4 Western blotting.
2.3. Western blot analysis of gastrointestinal
tissue for PrP
TSE
For Western blot analyses of gastrointestinal
tissue samples, hamsters (n ≥ 3 animals for each
examined time point) were sacriﬁced by CO2
asphyxiation at 3, 14, 30, 60, 100, and 130dpi
(see Fig. 1). The entire small intestine was
removed, carefully processed to eliminate residual
content, and subdivided into 20 segments of about
2cm in length weighing between 50 and 100mg.
The tissue samples were frozen immediately in
liquid nitrogen and stored at −80 ◦C until further
processing. After digestion by collagenase and
further tissue disintegration by ultrasoniﬁcation,
PrP
TSE was extracted in the form of PrP27-30 as
described elsewhere [4]. Samples from the small
intestine of parallel mock-infected hamsters served
as negative controls; samples from uninfected
hamsters spiked with 263K scrapie hamster brain
homogenate containing 10−6 g of scrapie brain
tissue were used as positive controls (not shown).
At 60, 70, 80, 100, and 130dpi (n = 1, 1, 1,
2, and 4 hamsters, respectively) caeca and large
intestines as well as the stomachs and oesophagi
were removed from sacriﬁced animals. These tissue
specimens, after removal of residual content, were
dissected into pieces of between 50 and 100mg
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Figure 2. (A) Immunological cross-reactivity of hamster faeces in the Western blot (labeling with mAb
3F4). Lanes 1 and 4: PK digested 263K scrapie hamster brain homogenate containing 5 × 10−7 go f
brain tissue. Lanes 2 and 3: Crude homogenates from 2mg of normal hamster faeces. Lanes 5 and 6:
Puriﬁed extracts from 100mg of normal hamster faeces. (B) Semi-quantitative Western blot assessment
of the extraction recovery of PrP27-30, the PK-resistant core of PrP
TSE, from hamster faeces spiked with
263K scrapie brain homogenate. Lanes 1–5, 9–13 and 17–21: Serially diluted 263K scrapie hamster brain
homogenate containing 1 × 10−6 g( l a n e s1a n d9 ) ,7× 10−7 g (lanes 2 and 10), 5 × 10−7 g (lanes 3 and
11), 2.5 × 10−7 g (lanes 4, 12 and 17), 1 × 10−7 g (lanes 5, 13 and 18), 5 × 10−8 g (lane 19), 2 × 10−8 g
(lane 20) and 1 × 10−8 g (lane 21) tissue. Lanes 6-8: Extracts from 200mg normal hamster faeces spiked
with 5 × 10−6 g of homogenized 263K scrapie brain tissue before puriﬁcation. Lanes 14-16: Extracts from
−→
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and subjected to extraction and Western blotting
of PrP27-30. Negative and positive controls were
prepared as described above.
2.4. Immunohistochemistry and PET blotting
for PrP
TSE detection in intestinal samples
For immunohistochemical detection of intesti-
nal PrP
TSE deposition in situ, hamsters were
transcardially perfused with periodate lysine
paraformaldehyde (PLP) [31] immediately after
CO2 euthanasia performed at 3dpi (n = 2), and 14,
30, 45 and 60dpi (n = 6 for each time point), or at
the terminal stage of clinical scrapie (n = 3) (see
Fig. 1). The distal half of the small intestine was
removed and subdivided into 10 segments of about
2cm in length. Segments from mock-infected ani-
mals served as negative controls while terminally ill
animals provided intestinal specimens for positive
controls. After washing in TBS and postﬁxation for
5h in PLP, the samples were dehydrated in ethanol
and embedded in parafﬁn-wax. For microscopic
investigation,6mmicrotomesectionsweretreated
withformicacidandimmunostainedusingthemon-
oclonal antibody (mAb) 3F4 [27] and diaminoben-
zidine as described elsewhere [32]. Normal mouse
serum replaced mAb 3F4 in adjacent sections
as the internal control for staining speciﬁcity.
Additionally, 6m microtome slices were mounted
onto nitrocellulose membranes and processed for
PrP
TSE detection by PET blotting as described
previously [41,45].
The time scale in Figure 1 displays the pre-
clinical and clinical phases of incubation of
hamsters orally infected with 263K scrapie (see
also [46]), and indicates the time points at which
samples from the animals were tested for PrP
TSE.
3. RESULTS
3.1. Western blot detection of PrP
TSE in faeces
3.1.1. Speciﬁcity, sensitivity and yield of the
extraction method
The monoclonal antibody 3F4 has long
since been established as an exquisite
immunological probe for Western blot
detection of normal and pathological prion
protein of hamsters. However, as shown
in Figure 2A (lanes 2 and 3), direct PrP
analysis of raw hamster faeces by Western
blotting is not feasible due to substantial
unspeciﬁc cross-reactivity with various stool
components.
Our protocol for the extraction of PrPTSE
from faeces removed such interfering com-
ponents (Fig. 2A, lanes 5 and 6) and reliably
allowed detection of PrP27-30 in positive
control samples of 200mg faeces spiked with
5 × 10−7 g of homogenized 263K scrapie
Figure 2 (continued). 200mg normal hamster faeces spiked with 3 × 10−6 g of homogenized 263K scrapie
brain tissue before puriﬁcation. Lanes 22–23: Extracts from 200mg normal hamster faeces spiked with
5 × 10−7 g of homogenized 263K scrapie brain tissue before puriﬁcation. (C) Western blot detection of
PrP27-30, the PK-resistant core of PrP
TSE, in faeces of hamsters fed with 263K scrapie brain homogenate.
Lanes 1–5: Serially diluted 263K scrapie hamster brain homogenate containing 5 × 10−6 g (lane 1),
1 × 10−6 g (lane 2), 2.5 × 10−7 g (lane 3), 1 × 10−7 g (lane 4) and 2.5 × 10−8 g (lane 5) tissue. Lanes
6-21: Extracts from 200mg faeces sampled at 0–24hpi (lanes 6-9), 24–48hpi (lanes 10-13), 48–72hpi
(lanes 14–17) and 72–96hpi (lanes 18–21) from 4 different animals. (D) Western blot detection of PrP27-
30, the PK-resistant core of PrP
TSE, in faeces of hamsters fed with 263K scrapie brain homogenate –
Adjustment of dilutions for semi-quantitative assessment of PrP
TSE excretion. Lanes 1–5: Serially diluted
263K scrapie hamster brain homogenate containing 5 × 10−7 g (lane 1), 2.5 × 10−7g (lane 2), 1 × 10−7 g
(lane 3), 5 × 10−8g (lane 4) and 2 × 10−8 g (lane 5) tissue. Lanes 6–9: 1:2 (lanes 6 and 8) and 1:5 (lanes 7
and 9) diluted extracts from 200mg faeces sampled at 24–48hpi (dilutions were prepared from the extracts
represented in lanes 10 and 12 of Fig. 2C). (E) Western blot detection of PrP27-30, the PK-resistant core
of PrP
TSE, after serial protein misfolding cyclic ampliﬁcation (sPMCA) of PrP
TSE in faeces extracts from
clinically diseased scrapie hamsters fed with 263K scrapie agent. Lane 1: 263K scrapie hamster brain
homogenate containing 5 × 10−7 g tissue. Lanes 2–11: sample signals of extracts from 200mg faeces of
two donor animals after 200 (lanes 2 and 3), 250 (lanes 4 and 5), 300 (lanes 6 and 7), 350 (lanes 8 and 9)
and 400 (lanes 10 and 11) cycles of sPMCA.
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Figure 3. (A) Western blot detection of PrP27-30, the PK-resistant core of PrPTSE, in segments of the small
intestine from hamsters fed with 263K scrapie brain homogenate. Lane 1: Blot control, 263K scrapie hamster
brain homogenate containing 1 × 10−7 g of brain tissue. Lanes 2 to 5: Samples collected at 30dpi (weak speciﬁc
immunostaining signals for PrPTSE in lanes 3 and 5 are marked by arrowheads). Lanes 6 to 9: Samples collected
at 60dpi (adjacent intestinal samples were blotted in lanes 6 and 7, and in lanes 8 and 9). Lanes 10 to 15: Samples
collected at 100dpi (adjacent intestinal samples were blotted in lanes 10 and 11, and in lanes 12–15; the pattern
shown in lanes 12–15 would be compatible with bi-directional spread of infectivity in the wall of the intestinal
tract. Lanes 16 and 17: Samples collected 130dpi. Note: Positive samples at 100 and 130dpi also show strong
staining of PrP27-30 dimers. (B) Range of western-blot signals from different segments of small intestine from
uninfected hamsters after PrPTSE puriﬁcation and staining with mAb 3F4. Lane 1: Blot control, 263K scrapie
hamster brain homogenate containing 1 × 10−7 g of brain tissue. Lanes 2–11: Unspeciﬁc immunostaining in
extracts from different segments of the small intestine of uninfected hamsters. Lane 12: Positive control; tissue
sample collected at 60dpi from the small intestine of a hamster orally infected with 263K scrapie. (C) Initial sites,
foci, and spread of PrPTSE-deposition in the small intestine of hamsters fed with 263K scrapie brain homogenate.
Schematic summary of Western blot ﬁndings in screened segments of small intestines collected 3, 14, 30, 60, 100
and 130dpi. n = number of animals investigated.
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brain tissue (Fig. 2B, lanes 22 and 23). The
staining intensities of the extracts in lanes
22 and 23 were comparable to that of the
reference sample in lane 20 (representing
2 × 10−8 g of scrapie brain tissue). This
indicates that our extraction method recovered
in the ﬁnal extract ∼4% of the faecal PrPTSE
spike. The staining intensities of extracts from
samples spiked with 3 × 10−6 g of homog-
enized 263K scrapie brain tissue (Fig. 2B,
lanes 14–16) resembled those of the reference
signals in lanes 13 and 18 (each representing
1 × 10−7 g of scrapie brain tissue), suggesting
an extraction yield of ∼3%. Higher amounts
of spiking material (i.e. 5 ×10−6g; Fig. 2B,
lanes 6–8) resulted in slightly increased
retrieval rates of ≥5%.
3.1.2. Faecal shedding of PrPTSE
After feeding scrapie brain homogenate to
our model animals, faecal excretion of PrPTSE
could be observed consistently in samples
collected at 24–48hpi and 48–72hpi (Fig. 2C,
lanes 10–13 and 14–17, respectively). In
contrast, no PrP27-30, the PK-resistant core of
PrPTSE, was detected by Western blotting of
extracts from specimens collected at 0–24hpi
(Fig. 2C, lanes 6–9), 72–96hpi (Fig. 2C,
lanes 18–21), or at later preclinical time
points that were examined in our study, i.e.
at 70, 100, and 130dpi, as well as at the
clinical stage of disease (not shown). Thus,
the observed retention period of the inoculum
in the gastrointestinal tract was found to
be ≤3 days. However, PMCA increased the
sensitivity of PrPTSE detection in faeces and
revealed that small amounts of the protein
were present in faecal extracts from 2 out
of 4 clinically-ill scrapie hamsters that were
tested (Fig. 2E). Extracts from normal hamster
faeces consistently produced negative results
after sPMCA (not shown).
3.1.3. Fate of ingested PrPTSE
Hamsters shed between 2–4g of faeces
per day during the ﬁrst 96h after infection.
Together with this observation, a semi-
quantitative comparison of test- and reference
samples in Figures 2C and 2D allowed to
assess the proportion of ingested PrPTSE that
had been faecally excreted. In the following,
such an assessment is exempliﬁed for one
animal for which the faecal extracts from
samples collected at 0–24hpi, 24–48hpi,
48–72hpi and 72–96hpi have been blotted in
lanes 6, 10, 14 and 18 of Figure 2C, respec-
tively. For 0–24hpi and 72–96hpi no PrPTSE
could be detected. However, the staining
intensity observed for 24–48hpi (Fig. 2C,
lane 10) corresponded approximately to that
of 1 × 10−6 g scrapie hamster brain tissue
(Fig. 2C, lane 2). Therefore, taking the
extraction yield determined above (∼4%) into
account, it can be concluded that the examined
faecal sample (200mg) contained an amount
of PrPTSE which was equivalent to that present
in 2.5 × 10−5 g of homogenized scrapie ham-
ster brain. For the interval of 48–72hpi the
staining intensity of the faeces sample from
the animal (Fig. 2C, lane 14) resembled that
of 2.5 × 10−7 g scrapie hamster brain tissue
(Fig. 2C, lane 3), suggesting that the amount
of PrPTSE in this sample (again 200mg)
corresponded to that in 6.25 × 10−6 g scrapie
hamster brain tissue. Accordingly, with about
3g faeces shed per day, the animal excreted
an amount of PrPTSE equivalent to that present
in approximately 15 × 2.5 × 10−5g + 15 ×
6.25 × 10−6g = 4.7 × 10−4 g of scrapie ham-
sterbraintissue,i.e.about4.7%oftheingested
PrPTSE. Similar assessments performed for the
samples of the three other examined animals
displayed in Figure 2C (lanes 7–9, 11–13, 15–
17 and 19–21), and with further dilutions of
faecal extracts as shown in Figure 2D, indicate
that on average 5% of the orally administered
PrPTSE had been shed via the faeces.
3.2. Western blot detection of PrP
TSE in tissue
specimens of the gastrointestinal tract
Western blot examination of gut segments
from the small intestine failed to detect PrPTSE
at 3 and 14dpi (Fig. 3C). Initial detection of
the protein was achieved at 30dpi in individual
segments of the distal jejunum and ileum in 1
out of 3 animals examined (Figs. 3A and 3C).
At 60dpi, Western blot signals for PrP27-30
(page number not for citation purpose) Page 7 of 17Vet. Res. (2009) 40:04 D. Krüger et al.
became more prominent and widespread, and
isolated foci of deposition were also observed
in the border region of the distal duodenum
and proximal jejunum (Figs. 3A and 3C). At
100dpi, positive signals in the distal jejunum
and ileum showed increasing conﬂuence, and
at 130dpi the entire wall of the small intestine
exhibited prominent deposition of PrPTSE in
the majority of examined animals (Figs. 3A
and 3C). First immunoblot detection of focal
PrPTSE in caudal intestinal regions (caecum,
colon) occurred at 100 dpi; cranially, initial
detectable deposition of PrPTSE was found in
stomach samples at 130dpi in 4 hamsters; in 2
out of these 4 animals also the oesophagi were
observed to show onset of PrPTSE deposition
(data not shown).
Extracts from gut specimens of uninfected
hamsters showed a variety of unspeciﬁc
staining signals with mAb 3F4 in the
Western blot (Fig. 3B) which could all be
clearly differentiated from PrP27-30. These
unspeciﬁc signals may have resulted from
heterogeneous compounds in the resorptive
tissue, depending on the status of the uptake
and processing of nutrients, and on differences
in the exact tissue composition of the various
specimens from the gut wall.
3.3. Immunohistochemical and PET blot
detection of PrP
TSE in tissue specimens
from the distal small intestine
Since prion invasion of alimentary tract
tissue showed its initial manifestation (in
terms of the deposition of PrPTSE)i nt h e
distal small intestine of our model animals,
this gut region was further scrutinized by
immunohistochemistry and PET blotting for
the detection of PrPTSE in GALT and ENS
components. Initial foci of PrPTSE deposition
were detected at 30dpi (in 5 out of 6
animals, Fig. 4D and Tab. I) and at 45dpi
(in all 6 animals investigated, Figs. 4A–4C
and Tab. I) in germinal centers of Peyer’s
patches. Immunohistochemical observations
at 45 dpi (Fig. 4A) could be conﬁrmed by
PET blotting of adjacent sections for PrPTSE,
which visualized PrPTSE by granular, blue-
magenta staining (Fig. 4B). In contrast, the
Table I. Immunohistochemical monitoring of
PrP
TSE deposition in the GALT and ENS of the
distal small intestine from hamsters fed with 263K
scrapie brain homogenate.
No. of animals tested positive for PrPTSE/
No. of animals in group
3 dpi 14 dpi 30 dpi 45 dpi 60 dpi
G A L T 0/2 0/6 5/6 6/6 6/6
E N S 0/2 0/6 0/6 0/6 2/6
ENS did not show deposition of detectable
PrPTSE at 30 or 45dpi. At 60dpi PrPTSE
was found more frequently and widespread
in lymphoid follicles in all 6 animals
investigated (Figs. 5A–5D and Tab. I) where
the protein also often showed co-localisation
with macrophages of the dome (Fig. 5D, white
arrows). In 1 of the 6 animals showing PrPTSE
deposition in the GALT at 60dpi, PrPTSE was
also detected in association with submucosal
nerve-like structures of a lymphoid follicle
(Fig. 5C, white arrowheads), and with cells
of the follicle associated epithelium (FAE,
Fig. 5D, black arrowheads). At the clinical
stage of disease the GALT, and particularly
Peyer’s patches, consistently showed strong
immunolabeling for PrPTSE in all examined
intestinal samples (not shown). ENS ganglia
were positive for PrPTSE in only 2 out of
6 animals investigated at 60dpi (Tab. I,
Figs. 6A and 6B), but at the terminal stage of
scrapie, PrPTSE was abundant in submucosal
and myenteric plexuses in the small intestine
(Fig. 6C). The results obtained in our immuno-
histochemical examinations from 3 to 60dpi
are summarized in Table I.
4. DISCUSSION
4.1. Intestinal fate of ingested PrP
TSE
To address the intestinal fate of ingested
PrPTSE, we ﬁrst examined the shedding of
PrPTSE in the excrement of orally challenged
hamsters around the time-point of infection
and the presence of PrPTSE in components of
the gut wall at 3 and 14dpi. We consistently
detected pathological prion protein in faeces
of the animals at 24–48h and 48–72h after
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Figure 4. Photomicrographs displaying granularly stained PrP
TSE detected by immunohistochemical
labeling (A, C, D) or PET blotting (B) at 30 or 45dpi in the GALT of hamsters fed with 263K scrapie
brain homogenate. PrP
TSE appears as brown (A, C, D) or blue-magenta (B) granular material. (A) Ileal
lymphoid follicle at 45dpi showing PrP
TSE in the germinal centre (arrowhead and inset in A). (B) PET blot
in adjacent section to the specimen displayed in A (PrP
TSE is indicated by arrow). (C) Higher magniﬁcation
of inset in A. (D) Detection of PrP
TSE in the germinal center of an ileal lymphoid follicle at 30dpi. Scale bars
in A and B, 40m; in C and D, 5m. (For a colour version of this ﬁgure, please consult www.vetres.org.)
peroral uptake of infectious scrapie brain
homogenate within the limits of our test
sensitivity, but not at 0–24hpi or later than
72hpi. Our ﬁndings showed that the animals
shed on average 5% of the perorally inoculated
PrPTSEin the faeces. On the contrary, PrPTSE
could not be detected by Western blotting,
PET blotting or immunohistochemistry in
specimens of the gut wall at 3dpi and 14dpi.
Thus, a large proportion (i.e. about 95%) of
the originally inoculated PrPTSE apparently
disappeared from the intestinal tract.
This clearance seems most likely to have
been mediated by degradation, which would
be consistent with previous observations by
Jeffrey et al. [25] that scrapie-associated
PrPTSE is readily digested by ﬂuids of the
alimentary tract from sheep. Resorption and
conveyance to extra-intestinal sites such
as peripheral lymph nodes [21] or other
LRS components could provide an alter-
native explanation for the observed PrPTSE
clearance. However, in our model animals
drainage of inoculum to LRS components out-
side the gut may be of lower importance for
the intestinal clearance than degradation, since
infectivity and PrPTSE were found only rela-
tively late (i.e. subsequently to invasion of the
brain and spinal cord) in the spleen of ham-
sters orally challenged with scrapie [5]. Apart
from the shed or cleared proportions of the
ingested PrPTSE, an indiscernible fraction of
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Figure 5. Photomicrographs displaying PrP
TSE detected by immunohistochemical staining at 60dpi in the
GALT of a hamster fed with 263K scrapie brain homogenate (A–D). Lymphoid follicle from the distal
jejunumshowinggranulardepositsofPrP
TSE inthegerminalcenter(A,middleinset;B,highermagniﬁcation
of middle inset in A), in submucosal nerve-like structures (A, left inset; C, higher magniﬁcation of left inset
in A, white arrowheads), in cells of the FAE and in macrophages of the dome (A, right inset; D, higher
−→
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the perorally administered inoculum triggered
intestinal infection as evidenced by progress-
ing PrPTSE accumulation in components of the
gut wall.
4.2. Course of PrP
TSE deposition in the GALT
and ENS
In order to identify the regions of initial
PrPTSE deposition in the gastrointestinal tract
of orally challenged hamsters we screened
samples from the oesophagus, stomach, small
intestine, caecum and large intestine by
Western blotting. This revealed the distal
jejunum and ileum as the most prominent sites
containing initial foci of PrPTSE deposition.
Such foci, which were observable at 30dpi in
our model animals, probably did not represent
the original inocula (since no PrPTSE could be
detected by Western blotting at 3 and 14 dpi)
but most plausibly resulted from replication
of the agent at sites of primary infection. In
contrast, detectable PrPTSE deposition in tested
segments from the large intestine, stomach or
oesophagus was found to start signiﬁcantly
later, i.e. between 100 and 130dpi. This was
rather indicative of secondary infection that
may have occurred by spread within the wall
of the alimentary tract or from other parts of
the body.
In the distal small intestine, primary
infection of tissue with ingested inoculum
may have been particularly facilitated by
the relatively abundant presence of Peyer’s
patches [17], and by an increased contact of
infectious inoculum with the luminal surface
of the intestinal wall due to a physiologically
delayed ileal transit time [20]. Peyer’s patches
of the caudal jejunum and ileum were also
described to accumulate PrPTSE early in the
pathogenesis of natural sheep scrapie [2,51].
Similarly, in BSE-infected cattle, where the
presence of infectious agent is essentially con-
ﬁned to the brain, spinal cord and retina [12],
the BSE agent was detected in the distal
ileum during preclinical and clinical phases
of incubation after experimental peroral
challenge [19,53,54].
According to the results of our Western blot
study, and building on the course of infection
in the GALT and ENS of perorally infected
hamsters that had been established in previous
studies for the period of time between 69 dpi
and terminal disease [7, 33], we focused on
the distal small intestine to further probe the
early PrPTSE deposition in the gut wall by
immunohistochemistry and PET blotting at
3, 14, 30, 45 and 60dpi. For our immunohis-
tochemical analysis, only staining signals of
clearly recognizable granular deposits (but not
homogeneous brown immunolabeling) were
considered as indicative of PrPTSE [6].
Our examinations provided negative results
at 3 and 14dpi, but demonstrated the presence
of PrPTSE in Peyer’s patches of the GALT
in the majority of animals at 30 and 45dpi
(Tab. I). At 30dpi the immunohistochemical
staining for PrPTSE was often restricted to
only one or two 6m sections, indicating
that a rather limited number of follicular
dendritic cells (FDC) was involved in the
detected initial deposition of the protein. At
60dpi IHC revealed the presence of PrPTSE not
only in the FDC network but also associated
with membranous epithelial cells (possibly M
cells) of the FAE [7], macrophages of the
dome und submucosal nerve-like structures
(Figs. 5C and 5D). In contrast to the GALT, the
onsetofPrPTSE depositioninENScomponents
such as myenteric plexuses were found not
earlier than 60dpi (Tab. I, Figs. 6A and 6B).
Figure 5 (continued). magniﬁcation of right inset in A, black arrowheads and white arrows, respectively).
Scale bars in A, 40m; in B, C and D, 5m. Photomicrographs of a lymphoid follicle from the distal ileum
of an uninfected hamster labeled immunohistochemically with mAb 3F4 (E–G). Unspeciﬁc homogeneous
brownstaininginthegerminalcenter(E,middleinset;F,highermagniﬁcationofmiddleinsetinE).Granular
immunostaining for PrP
Sc deposits is absent in the submucosal region (E, left inset; G, higher magniﬁcation
of left inset in E), or in the FAE (E, right inset; H, higher magniﬁcation of right inset in E). Scale bars in E,
40m; in F, G and H, 5m. (For a colour version of this ﬁgure, please consult www.vetres.org.)
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Figure 6. Photomicrographs displaying PrP
TSE detected by immunohistochemical staining at 60dpi (A,
B) and at the clinical stage of scrapie (160dpi, C) in myenteric ganglia of the ileal ENS of hamsters fed
with 263K scrapie brain homogenate. Scale bars 5m. (For a colour version of this ﬁgure, please consult
www.vetres.org.)
At the terminal stage of scrapie, PrPTSE was
consistently present in both GALT and ENS,
as has already been established in previous
studies that found progressing accumulation of
PrPTSE in these intestinal tissues of hamsters
orally challenged with scrapie from 69dpi
(the earliest time point available) until clinical
disease [7,8,33].
Recently, Bergström et al. [9] reported
immunohistochemical detection of PrPTSE in
Peyer’s patches already 2, 4 and 8 days after
oral infection of hamsters with 263K scrapie
agent. In this study, a tenfold higher dose of
agent than that used by us was administered
to the animals which may account for the
difference in the time points for the initial
detection of GALT-related PrPTSE found by
these authors and us. Bergström et al. [9]
concluded that “Peyer’s patches constitute
at least one of the primary entry sites of
PrPSc after oral exposure to scrapie”. By
examination of the ENS additionally to the
GALT, our study sheds further light on
the sequence of PrPTSE deposition in these
intestinal tissue components. The ﬁndings
described above show that at intestinal sites
of putatively primary infection the onset
of detectable PrPTSE deposition in lymphoid
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tissue clearly preceded that in submucosal or
myenteric ganglia. If the observed temporal-
spatial pattern of PrPTSE deposition in the
examined intestinal tissue samples correctly
reﬂects the spread of infection, this would be
indicative of the GALT being involved in both,
establishment of primary intestinal infection
and propagation of infection to the ENS in
our model animals. Whether blood or lymph is
involved in the spread of infection to the ENS
has not yet been elucidated and would require
further examination.
Findings in other murine models suggest
that neuroinvasion can also occur in the
absence of detectable lymphoid infection, e.g.
after oral challenge by a high dose of agent
or exposure to highly neuroinvasive TSE
strains [8]. Furthermore, although comprehen-
sive studies in Texel sheep naturally infected
with scrapie [50] suggested that the proximity
of Peyer’s patches and plexuses of the ENS
may facilitate neuroinvasion, in sheep carrying
the genotype PrPVRQ/ARR CNS invasion is
reported to occur without preceding infection
of lymphoid tissue [51]. Also, a subset of
sheep orally infected with BSE showed inva-
sion of the CNS without detectable PrPTSE
in the lymphoid system [24]. Thus, it has to
be noted that the intestinal routing of prions
after ingestion of infectivity may considerably
vary depending on the combination of the
prion strain, dose of the agent and host
species.
4.3. Shedding of endogenously formed PrP
TSE
in faeces
The deposition of substantial amounts of
PrPTSE, particularly associated with Peyer’s
patches, in close vicinity to the lumen of
the small intestine found here and in other
studies both before and after the onset of
clinical symptoms [9,49,53] is suggestive of
a further role of the GALT in the pathogenesis
after oral scrapie infection. This role would
be to provide a source for dissemination of
replicated prions from the gut wall into faeces.
We found PrPTSE in membranous epithelial
cells of the FAE directly adjacent to the
intestinal lumen, and release of viruses from
the apical (or luminal) surface of polarized
intestinal epithelial cells has been described
in a variety of reports [14, 48]. Deposition
of PrPTSE in FAE components has been
observed already previously in orally infected
hamsters [7] and in BSE-infected lemurs [10].
However, so far, FAE components such as
M cells are discussed primarily as candidate
sites of prion entry into the gut wall [7, 18].
Our ﬁndings point to a second or alternative
role of the FAE in the pathogenesis of orally
acquired scrapie and indicate that the FAE
may serve as a site for prion release from the
host. Theoretically, such dissemination may
also arise from other intestinal tissues such
as infected ENS, but with respect to their
load of PrPTSE and anatomical location Peyer’s
patches would appear as the prime candidate
source of intestinal prion release.
However,aftertheinitialsheddingobserved
at 24–72hpi we ﬁrst failed to detect PrPTSE
by Western blotting of faecal extracts at
any time point tested during the preclinical
or clinical stage of infection. Our analytical
extraction procedure, which recovered ∼4%
of the faecal PrPTSE spike in the ﬁnal
extract, was able to detect PrPTSE when an
amount of5 × 10−7 gofscrapiehamsterbrain,
i.e. ∼50 pg of PrPTSE [5], was added to
200mg of faeces and an extract representing
200mg of spiked faeces was loaded onto
the gel for Western blotting. As known
from previous titrations [3, 5], such spikes
contained about 0.5–1.5 × 103 intracerebral
(i.c.) infective doses (LD50i.c.).Accordingly,
unknown faecal samples (of which extracts
representing 200mg of starting material
were loaded for Western blotting) should
have produced positive results if they had
contained an amount of PrPTSE corresponding
to ≥5 × 10−7 g of scrapie hamster brain
per 200mg of faeces (i.e. ≥2.5 × 10−6 go f
scrapie hamster brain per 1g of faeces).
When the exogenous spiking material is
representative of endogenous PrPTSE in faeces,
ourobservationssuggestthattheconcentration
of PrPTSE in faeces from negatively tested
donors was at least 400000-fold lower than
that in the brain. If, furthermore, in faeces
PrPTSE correlates with infectivity in a similar
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ratio to that observed previously in the CNS
[3,5], this would indicate that infectivity in the
faeces, if present, would be lower than 2.5 to
7.5 × 103 LD50 per gram.
In order to examine whether excretion of
PrPTSE by shedding from infected Peyer’s
patches (as also recently suggested by Safar
et al. [39]) or other contaminated components
of the gut wall occurred at low levels
not detectable by direct Western blotting
when intestinal PrPTSE deposition had been
established, we performed serial PMCA of
faecal extracts from clinically-ill scrapie
hamsters. This revealed the presence of small
amounts of PrPTSE that eluded detection when
such extracts were analysed without in vitro
ampliﬁcation of the pathological prion protein.
Excrement may thus also provide a vehicle for
the release of endogenously formed PrPTSE.
In the light of the data available so far, this
release seems to occur predominantly from
Peyer’s patches, possibly under involvement
of the FAE. However, the rather low level of
contamination found in faeces from clinically-
ill animals suggests that such a mode of prion
dissemination is at least partially counteracted
by the observed ability of the digestive tract to
clear substantial amounts of PrPTSE from the
alimentary canal.
4.4. Previous reports on the excretion and
d e t e c t i o no fp r i o n si nf a e c e s
A recent study on the excretion of scrapie
and BSE-associated PrPTSE in stools of
intragastrically challenged mice [29] reported
remarkably similar results to our observations
with respect to the shedding kinetics of PrPTSE
around the time-point of infection, despite
differences in the route of inoculation, dose
and strain of the agent, and host species. This
may be indicative of common characteristics
in the alimentary processing of ingested
PrPTSE. However, the mouse study did not
address the intestinal fate of ingested PrPTSE
in detail and failed to detect the protein in
samples from mice clinically affected with
scrapie.
Safar et al. [39] recently addressed the
transmission and detection of prions in
faeces from hamsters orally challenged with
Sc237 scrapie agent (presumably identical
to 263K scrapie). These authors found that
faecal shedding of PrPTSE, as determined by
conformation dependent immunoassay (CDI),
peaked at 2 days after infection and then
gradually decreased for the next 16 days. From
20dpi until the onset of scrapie symptoms,
the CDI detected ﬂuctuating levels of PrPTSE
in the excrement. The highest infectivity
levels in faeces, as determined by bioassay,
were detected at 2 and 8dpi, and excretion
of prions then continued at lower levels
throughout the entire asymptomatic phase of
incubation. The pronounced faecal shedding
of PrPTSE and infectious prions observed by
Safar et al. [39] may have resulted from the
very high dose of agent perorally administered
in this experiment (the animals were fed
one-half of a scrapie hamster brain which
corresponds to about 500mg of brain tissue).
Such a dose possibly “overwhelmed” the
digestive system [11] and compromised its
ability to clear PrPTSE as efﬁciently from the
alimentary tract as observed when hamsters
werefedalower amount (i.e.10mg)ofscrapie
brain homogenate.
Using different doses for peroral infection,
thestudybySafaretal.andourworkproduced
complementary ﬁndings. By administering a
relatively low dose of agent, we were able to
elucidate the fate of the ingested PrPTSE in
more detail. Furthermore, our immunohisto-
chemical and PET blot examinations of the gut
wall experimentally substantiated the notion
discussed by Safar et al. [39] that contamina-
tion of faeces with prions may be mediated by
shedding from infected Peyer’s patches.
4.5. The possible role of faeces in the
transmission of contagious prion diseases
With respect to previously raised assump-
tions that contaminated excrements may be
involved in the horizontal transmission of
natural sheep scrapie in endemically affected
ﬂocks [2], several different aspects have to be
considered: First, ruminants have a speciﬁc
LRS component at the recto-anal junction,
(sometimes referred to as “RAMALT”) which
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accumulates PrPTSE, and from where possibly
contaminated macrophages may be released
into the very distal gut lumen [16] and shed
into the environment. Second, ruminants
shed relatively large quantities of faeces, and
binding of prions to soil may substantially
enhance the efﬁciency of peroral scrapie
transmission [26]. Third, speciﬁc factors
could possibly enhance dissemination of
PrPTSE from the gut wall. This holds partic-
ularly true for injuries that may lead to the
shedding of intestinal tissue debris, parasitic-
or other co-infections [23, 35], and inﬂam-
matory processes [42]. Apart from faeces,
other vehicles have been discussed for TSE
transmissions in the ﬁeld, e.g. contaminated
placenta, decomposed carcasses, saliva, urine
or skin [15, 30, 34, 38, 42, 46]. Our protocol
for the detection of PrPTSE in faeces combined
with sPMCA can help to test excrements from
ovines, caprines or cervids in future studies
to further pinpoint the sources of infection in
contagious prion diseases of animals.
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